Chinese patent medicine tongxinluo capsule as a supplement to treat chronic coronary syndromes: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials
Frontiers in Cardiovascular Medicine
JANUARY 6, 2025
Evidence supports the use of TXL plus WM for reducing angina frequency [SMD 2.50, 95% CI (3.53, 1.48)], improving seattle angina questionnaire scores (P<0.05), decreasing nitroglycerin dose [SMD 1.63, 95% CI (2.26, 1.00)], and shortening angina duration [MD 1.50min/once, 95% CI (1.98, 1.02)].
Let's personalize your content